| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Follicle | 17 | 2025 | 124 | 3.830 |
Why?
|
| Ovary | 20 | 2025 | 360 | 3.480 |
Why?
|
| Oocytes | 16 | 2025 | 279 | 3.050 |
Why?
|
| Sumoylation | 5 | 2025 | 40 | 2.940 |
Why?
|
| Granulosa Cells | 16 | 2019 | 141 | 2.720 |
Why?
|
| Fertility | 11 | 2025 | 263 | 2.270 |
Why?
|
| Reproduction | 5 | 2025 | 214 | 1.980 |
Why?
|
| Oogenesis | 7 | 2025 | 51 | 1.920 |
Why?
|
| Germ Cells | 6 | 2023 | 201 | 1.480 |
Why?
|
| Granulosa Cell Tumor | 10 | 2019 | 38 | 1.420 |
Why?
|
| Inhibins | 6 | 2013 | 85 | 1.350 |
Why?
|
| Smad Proteins | 5 | 2016 | 44 | 1.260 |
Why?
|
| Transforming Growth Factor beta | 8 | 2017 | 459 | 1.240 |
Why?
|
| Signal Transduction | 17 | 2021 | 4676 | 1.080 |
Why?
|
| Infertility, Female | 6 | 2025 | 150 | 1.030 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 3 | 2025 | 35 | 1.000 |
Why?
|
| Animals | 54 | 2025 | 33964 | 0.970 |
Why?
|
| Mice, Knockout | 25 | 2025 | 3839 | 0.960 |
Why?
|
| Mice | 39 | 2025 | 18239 | 0.950 |
Why?
|
| Primary Ovarian Insufficiency | 4 | 2021 | 51 | 0.930 |
Why?
|
| Giant Cells | 1 | 2025 | 33 | 0.910 |
Why?
|
| Homeodomain Proteins | 5 | 2023 | 568 | 0.900 |
Why?
|
| Myostatin | 1 | 2025 | 22 | 0.880 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 7 | 2011 | 294 | 0.880 |
Why?
|
| Estrous Cycle | 3 | 2025 | 40 | 0.790 |
Why?
|
| Ovarian Neoplasms | 6 | 2016 | 456 | 0.770 |
Why?
|
| Integrases | 2 | 2023 | 156 | 0.770 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2023 | 121 | 0.760 |
Why?
|
| Smad5 Protein | 3 | 2014 | 20 | 0.690 |
Why?
|
| Smad1 Protein | 3 | 2014 | 22 | 0.690 |
Why?
|
| Smad4 Protein | 3 | 2012 | 58 | 0.680 |
Why?
|
| Growth Differentiation Factor 9 | 7 | 2013 | 50 | 0.680 |
Why?
|
| Female | 53 | 2025 | 70938 | 0.640 |
Why?
|
| Transcription Factors | 8 | 2023 | 2450 | 0.610 |
Why?
|
| Cytokines | 4 | 2021 | 1349 | 0.600 |
Why?
|
| Meiosis | 4 | 2015 | 112 | 0.600 |
Why?
|
| Cell Communication | 1 | 2019 | 188 | 0.580 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 998 | 0.560 |
Why?
|
| Aging | 1 | 2025 | 1263 | 0.530 |
Why?
|
| Menopause | 1 | 2017 | 87 | 0.510 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2012 | 126 | 0.510 |
Why?
|
| Reproductive Health | 1 | 2017 | 48 | 0.500 |
Why?
|
| Gene Expression Regulation | 8 | 2014 | 2346 | 0.500 |
Why?
|
| Ovulation | 8 | 2012 | 105 | 0.490 |
Why?
|
| Oviducts | 1 | 2016 | 99 | 0.480 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2019 | 991 | 0.470 |
Why?
|
| Longevity | 1 | 2017 | 176 | 0.470 |
Why?
|
| Fallopian Tubes | 1 | 2016 | 70 | 0.470 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2015 | 20 | 0.470 |
Why?
|
| Uterus | 3 | 2016 | 548 | 0.460 |
Why?
|
| Spermatogenesis | 2 | 2015 | 171 | 0.440 |
Why?
|
| Activins | 4 | 2013 | 73 | 0.430 |
Why?
|
| Lipodystrophy | 2 | 2025 | 37 | 0.400 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2014 | 608 | 0.380 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2012 | 43 | 0.380 |
Why?
|
| Gonadotropins | 2 | 2015 | 31 | 0.360 |
Why?
|
| Egg Proteins | 2 | 2012 | 29 | 0.350 |
Why?
|
| Luteinization | 2 | 2010 | 12 | 0.320 |
Why?
|
| Adipose Tissue, White | 3 | 2025 | 95 | 0.300 |
Why?
|
| Embryo Implantation | 3 | 2016 | 221 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 4709 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2015 | 2028 | 0.290 |
Why?
|
| Inhibin-beta Subunits | 1 | 2007 | 19 | 0.270 |
Why?
|
| Humans | 32 | 2025 | 131223 | 0.240 |
Why?
|
| Testis | 2 | 2007 | 411 | 0.240 |
Why?
|
| Adipose Tissue, Beige | 1 | 2025 | 9 | 0.240 |
Why?
|
| Gonads | 1 | 2004 | 32 | 0.220 |
Why?
|
| Transforming Growth Factors | 1 | 2004 | 18 | 0.220 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 708 | 0.220 |
Why?
|
| Cell Cycle Proteins | 2 | 2009 | 699 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 589 | 0.210 |
Why?
|
| Carcinogenesis | 3 | 2019 | 350 | 0.210 |
Why?
|
| Proteins | 3 | 2023 | 1007 | 0.210 |
Why?
|
| Cell Differentiation | 5 | 2015 | 1931 | 0.210 |
Why?
|
| Gene Deletion | 3 | 2021 | 769 | 0.200 |
Why?
|
| Zygote | 1 | 2023 | 28 | 0.200 |
Why?
|
| Bone Morphogenetic Protein 15 | 5 | 2007 | 44 | 0.200 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 2340 | 0.190 |
Why?
|
| Male | 16 | 2025 | 64944 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 1227 | 0.190 |
Why?
|
| Mammals | 1 | 2023 | 251 | 0.190 |
Why?
|
| Lysine | 1 | 2023 | 165 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2015 | 1007 | 0.180 |
Why?
|
| Tissue Engineering | 1 | 2003 | 165 | 0.180 |
Why?
|
| Energy Metabolism | 2 | 2024 | 794 | 0.180 |
Why?
|
| Periodicity | 1 | 2021 | 48 | 0.180 |
Why?
|
| Bioreactors | 1 | 2002 | 44 | 0.180 |
Why?
|
| Models, Genetic | 1 | 2004 | 749 | 0.180 |
Why?
|
| Transcription, Genetic | 2 | 2007 | 1390 | 0.170 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4666 | 0.170 |
Why?
|
| Adipocytes, Brown | 1 | 2021 | 27 | 0.170 |
Why?
|
| Adipocytes, White | 1 | 2021 | 27 | 0.170 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 58 | 0.170 |
Why?
|
| Growth Substances | 1 | 2000 | 102 | 0.160 |
Why?
|
| Forkhead Transcription Factors | 2 | 2015 | 370 | 0.160 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2019 | 3 | 0.150 |
Why?
|
| Models, Biological | 4 | 2015 | 1392 | 0.150 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2010 | 187 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 626 | 0.150 |
Why?
|
| Smad2 Protein | 2 | 2009 | 54 | 0.150 |
Why?
|
| Smad3 Protein | 2 | 2009 | 54 | 0.150 |
Why?
|
| Neoplasms | 1 | 2013 | 2964 | 0.140 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2015 | 106 | 0.140 |
Why?
|
| Gene Expression Profiling | 3 | 2015 | 1845 | 0.140 |
Why?
|
| Genitalia | 1 | 2017 | 39 | 0.130 |
Why?
|
| Recombinant Proteins | 4 | 2007 | 1319 | 0.130 |
Why?
|
| Genetic Fitness | 1 | 2017 | 34 | 0.130 |
Why?
|
| Age Factors | 2 | 2017 | 2853 | 0.130 |
Why?
|
| Health Status Indicators | 1 | 2017 | 121 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2010 | 656 | 0.120 |
Why?
|
| Muscle, Smooth | 1 | 2016 | 119 | 0.120 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 1607 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 407 | 0.120 |
Why?
|
| Models, Animal | 1 | 2017 | 459 | 0.110 |
Why?
|
| Placentation | 1 | 2015 | 58 | 0.110 |
Why?
|
| Health Status | 1 | 2017 | 385 | 0.110 |
Why?
|
| Forkhead Box Protein O3 | 2 | 2015 | 31 | 0.110 |
Why?
|
| Cumulus Cells | 3 | 2010 | 42 | 0.110 |
Why?
|
| Tissue Distribution | 2 | 2006 | 365 | 0.100 |
Why?
|
| In Situ Hybridization | 2 | 2004 | 447 | 0.100 |
Why?
|
| Pregnancy | 5 | 2016 | 7571 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 146 | 0.100 |
Why?
|
| Activin Receptors, Type I | 1 | 2013 | 33 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 254 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2013 | 87 | 0.100 |
Why?
|
| Gene Expression | 3 | 2007 | 1495 | 0.100 |
Why?
|
| Ligands | 2 | 2004 | 487 | 0.100 |
Why?
|
| Base Sequence | 3 | 2006 | 2758 | 0.090 |
Why?
|
| Zona Pellucida Glycoproteins | 1 | 2012 | 8 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 232 | 0.090 |
Why?
|
| Organ Size | 1 | 2013 | 432 | 0.090 |
Why?
|
| Animals, Newborn | 3 | 2011 | 1017 | 0.090 |
Why?
|
| Enterococcus | 1 | 2012 | 30 | 0.090 |
Why?
|
| Drosophila melanogaster | 1 | 2017 | 849 | 0.090 |
Why?
|
| Membrane Glycoproteins | 2 | 2012 | 418 | 0.090 |
Why?
|
| Validation Studies as Topic | 1 | 2010 | 12 | 0.080 |
Why?
|
| Metagenome | 1 | 2012 | 143 | 0.080 |
Why?
|
| TATA-Binding Protein Associated Factors | 2 | 2007 | 14 | 0.080 |
Why?
|
| Transcription Factor TFIID | 2 | 2007 | 17 | 0.080 |
Why?
|
| Transfection | 1 | 2012 | 955 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2012 | 1015 | 0.080 |
Why?
|
| Forkhead Box Protein L2 | 1 | 2010 | 10 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 660 | 0.080 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2010 | 31 | 0.080 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 262 | 0.080 |
Why?
|
| Colitis | 1 | 2012 | 163 | 0.080 |
Why?
|
| Hedgehog Proteins | 2 | 2010 | 203 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1839 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 433 | 0.080 |
Why?
|
| Aromatase | 1 | 2009 | 23 | 0.080 |
Why?
|
| Receptors, FSH | 1 | 2009 | 20 | 0.080 |
Why?
|
| Sexual Maturation | 1 | 2009 | 46 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2019 | 827 | 0.080 |
Why?
|
| Apoptosis | 2 | 2014 | 1860 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 273 | 0.070 |
Why?
|
| Genomics | 1 | 2017 | 1620 | 0.070 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2009 | 45 | 0.070 |
Why?
|
| Multigene Family | 1 | 2010 | 289 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2480 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 1216 | 0.070 |
Why?
|
| Cell Line | 2 | 2004 | 2573 | 0.070 |
Why?
|
| Smad8 Protein | 1 | 2007 | 5 | 0.070 |
Why?
|
| Sertoli Cell Tumor | 1 | 2007 | 7 | 0.070 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2007 | 10 | 0.070 |
Why?
|
| Phosphofructokinase-1, Type C | 1 | 2007 | 7 | 0.070 |
Why?
|
| Corpus Luteum | 1 | 2007 | 24 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 328 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 2010 | 282 | 0.060 |
Why?
|
| Testicular Neoplasms | 1 | 2007 | 120 | 0.060 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2006 | 32 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2007 | 197 | 0.060 |
Why?
|
| Embryo, Mammalian | 2 | 2006 | 417 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2009 | 1520 | 0.060 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2005 | 9 | 0.060 |
Why?
|
| Thermogenesis | 1 | 2025 | 55 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 3499 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2007 | 2570 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2007 | 2922 | 0.060 |
Why?
|
| DNA Primers | 1 | 2006 | 606 | 0.060 |
Why?
|
| Steroids | 1 | 2006 | 170 | 0.060 |
Why?
|
| Spermatocytes | 1 | 2004 | 23 | 0.060 |
Why?
|
| Cholesterol | 1 | 2007 | 540 | 0.060 |
Why?
|
| Genes, Homeobox | 1 | 2004 | 61 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 2401 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2004 | 67 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2004 | 235 | 0.050 |
Why?
|
| Hexuronic Acids | 1 | 2003 | 6 | 0.050 |
Why?
|
| Glucuronic Acid | 1 | 2003 | 14 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2025 | 264 | 0.050 |
Why?
|
| Alginates | 1 | 2003 | 23 | 0.050 |
Why?
|
| Heterozygote | 1 | 2006 | 723 | 0.050 |
Why?
|
| Microspheres | 1 | 2003 | 68 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2005 | 208 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2004 | 585 | 0.050 |
Why?
|
| Fertilization in Vitro | 1 | 2004 | 154 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 314 | 0.050 |
Why?
|
| Phenotype | 1 | 2013 | 4483 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 716 | 0.050 |
Why?
|
| Hydrogels | 1 | 2003 | 94 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2004 | 332 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 11011 | 0.050 |
Why?
|
| Follicular Atresia | 1 | 2002 | 2 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2002 | 28 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 276 | 0.050 |
Why?
|
| Exons | 1 | 2004 | 763 | 0.050 |
Why?
|
| Chromatography | 1 | 2002 | 29 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 1055 | 0.050 |
Why?
|
| Paracrine Communication | 1 | 2002 | 68 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2007 | 1020 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 81 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2002 | 153 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2002 | 167 | 0.040 |
Why?
|
| Biological Assay | 1 | 2002 | 108 | 0.040 |
Why?
|
| Reference Standards | 1 | 2002 | 231 | 0.040 |
Why?
|
| Reference Values | 1 | 2002 | 686 | 0.040 |
Why?
|
| RNA | 1 | 2004 | 514 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2021 | 87 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1620 | 0.040 |
Why?
|
| Adipokines | 1 | 2021 | 121 | 0.040 |
Why?
|
| Receptors, Peptide | 1 | 2000 | 56 | 0.040 |
Why?
|
| Pituitary Gland | 1 | 2000 | 78 | 0.040 |
Why?
|
| Cyclin D3 | 1 | 2019 | 11 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2019 | 57 | 0.040 |
Why?
|
| Infant | 2 | 2016 | 13318 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2016 | 15016 | 0.030 |
Why?
|
| Body Composition | 1 | 2021 | 548 | 0.030 |
Why?
|
| Mutation | 2 | 2007 | 6152 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1996 | 30 | 0.030 |
Why?
|
| Child | 3 | 2016 | 26256 | 0.030 |
Why?
|
| Puberty, Precocious | 1 | 2016 | 29 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2016 | 161 | 0.030 |
Why?
|
| Hot Temperature | 1 | 1996 | 141 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2021 | 682 | 0.030 |
Why?
|
| Adolescent | 2 | 2016 | 20915 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 241 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 872 | 0.030 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2015 | 10 | 0.030 |
Why?
|
| Keratin-8 | 1 | 2015 | 13 | 0.030 |
Why?
|
| Lectins | 1 | 2015 | 50 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 394 | 0.030 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 49 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 101 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 414 | 0.030 |
Why?
|
| Genistein | 1 | 2014 | 39 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 64 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2015 | 90 | 0.030 |
Why?
|
| Animal Feed | 1 | 2014 | 76 | 0.030 |
Why?
|
| Decidua | 1 | 2015 | 145 | 0.030 |
Why?
|
| Trophoblasts | 1 | 2015 | 118 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 1996 | 263 | 0.030 |
Why?
|
| DNA-Binding Proteins | 2 | 2007 | 1957 | 0.030 |
Why?
|
| Time Factors | 1 | 2004 | 6257 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2013 | 38 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2015 | 344 | 0.020 |
Why?
|
| Adult | 4 | 2015 | 31440 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 1329 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 845 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2012 | 48 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2013 | 314 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 490 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 433 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2012 | 387 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2013 | 680 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 1277 | 0.020 |
Why?
|
| Hormones | 1 | 2010 | 164 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 1116 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2007 | 61 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 6, Group A, Member 1 | 1 | 2007 | 7 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 4955 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2007 | 213 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 3708 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 363 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 918 | 0.020 |
Why?
|
| Glycolysis | 1 | 2007 | 172 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2007 | 419 | 0.010 |
Why?
|
| X Chromosome | 1 | 2007 | 331 | 0.010 |
Why?
|
| Pyrroles | 1 | 2007 | 186 | 0.010 |
Why?
|
| Interferon Inducers | 1 | 2005 | 6 | 0.010 |
Why?
|
| Poly I-C | 1 | 2005 | 22 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 619 | 0.010 |
Why?
|
| RNA, Double-Stranded | 1 | 2005 | 58 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2007 | 272 | 0.010 |
Why?
|
| Hyaluronan Synthases | 1 | 2004 | 13 | 0.010 |
Why?
|
| Serum Amyloid P-Component | 1 | 2004 | 15 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 67 | 0.010 |
Why?
|
| Pregnancy Rate | 1 | 2004 | 39 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 124 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2005 | 253 | 0.010 |
Why?
|
| Interferons | 1 | 2005 | 136 | 0.010 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 64 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 329 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 128 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2007 | 363 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2004 | 170 | 0.010 |
Why?
|
| ROC Curve | 1 | 2004 | 615 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 619 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 574 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2004 | 455 | 0.010 |
Why?
|
| Activin Receptors | 1 | 2000 | 14 | 0.010 |
Why?
|
| Membranes | 1 | 2000 | 15 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12962 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 1219 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2000 | 78 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 436 | 0.010 |
Why?
|
| Cattle | 1 | 2000 | 501 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 783 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2000 | 812 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 2314 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 17714 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 1609 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 1996 | 30 | 0.010 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1996 | 33 | 0.010 |
Why?
|
| Heat Shock Transcription Factors | 1 | 1996 | 20 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1996 | 54 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1996 | 398 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1996 | 688 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 28669 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 980 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1996 | 351 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1996 | 731 | 0.010 |
Why?
|
| Monocytes | 1 | 1996 | 337 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2000 | 1088 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1996 | 359 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1996 | 168 | 0.010 |
Why?
|
| Rats | 1 | 2000 | 3434 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1996 | 1568 | 0.010 |
Why?
|
| DNA | 1 | 1996 | 1418 | 0.010 |
Why?
|
| Inflammation | 1 | 1996 | 1494 | 0.000 |
Why?
|